AI summarized from verified sources
AI improves challenging drug synthesis reaction, easing research bottlenecks
Drug candidate synthesis becomes more efficient, letting researchers test more ideas.
SOURCE CHECK
1 sources
Sources
Key Points
- 1TEMPO additive raised average yield from 16.6% to 25.2%
- 2Human chemists confirmed >2x improvement at bench scale
- 3Process from literature review to validation completed in 3 months
OpenAI paired GPT-5.4 with Molecule.one’s Maria AI to discover an additive that boosts Chan-Lam coupling yields. Across 10,080 automated experiments and human validation, yields improved for 88% of substrates. This makes molecule synthesis easier in drug development and accelerates research.
What happened
GPT-5.4 proposed TEMPO as an additive that significantly improved Chan-Lam coupling yields with primary sulfonamides. High-throughput experiments in Maria Lab were validated by human chemists.
Impact
The synthesis bottleneck in drug discovery is eased, allowing researchers to efficiently produce more molecules. This demonstrates how AI-lab collaboration can accelerate research going forward.
Briefs that include this news
Use daily, weekly, and monthly briefs to understand the surrounding context.
Daily / 2026-06-18
Google, OpenAI, and Anthropic release a series of AI announcements focused on enterprise adoption and practical use
Weekly / 2026-06-15 to 2026-06-21
AI News Summary for the Third Week of June 2026: Safety Operations, Migrations, and Enterprise Adoption Advance
Monthly / 2026-06-01 to 2026-06-30
June 2026 AI News Roundup: Anthropic Resumes Access and Expands Work Features, While Google and OpenAI Strengthen Practical Tools